Skip to content

The long term effectiveness of steroid injection for shoulder pain; a pragmatic randomised comparison with physiotherapy in primary care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN24540377
Enrollment
Unknown
Registered
2003-01-03
Start date
1998-06-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder pain Musculoskeletal Diseases Shoulder pain

Interventions

1. Methyl prednisolone (40 mg) and lignocaine by local injection 2. Physiotherapy

Sponsors

Arthritis Research Campaign (ARC) (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Males and females over 18 years with a clinical diagnosis of unilateral shoulder pain 2. First consultation with GP for this episode 3. Ability to understand and give informed consent

Exclusion criteria

Exclusion criteria: A history of inflammatory arthritis, polymyalgia rheumatica, or gross structural or neurological abnormality of the shoulder; contraindications to local steroid injection; history or examination leading to a suspicion of potentially serious disease; referred pain from neck or internal organs; clinical findings of ruptured rotator cuff; previous fracture or surgery to shoulder, upper limb, neck, or thorax; previous physical therapy for shoulder pain within the past 12 months; pregnancy or breast feeding.

Design outcomes

Primary

MeasureTime frame
The primary outcome was disability at 6 months measured using a shoulder disability Questionnaire.

Secondary

MeasureTime frame
Secondary outcomes included: participants? global assessment of change compared with baseline; rating of pain severity; impairment of function; severity of main complaint; ranges of movement; co-interventions.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026